- Report
- June 2022
- 88 Pages
Global
From €4719EUR$4,750USD£3,923GBP
- Report
- January 2022
- 115 Pages
Global
From €4719EUR$4,750USD£3,923GBP
- Report
- January 2022
- 110 Pages
Global
From €4719EUR$4,750USD£3,923GBP
- Report
- January 2022
- 110 Pages
Global
From €4719EUR$4,750USD£3,923GBP
- Report
- January 2022
- 122 Pages
Global
From €4719EUR$4,750USD£3,923GBP
- Report
- August 2023
- 182 Pages
Global
From €5216EUR$5,250USD£4,336GBP
€7451EUR$7,500USD£6,195GBP
- Report
- February 2023
- 30 Pages
Global
From €1912EUR$1,925USD£1,590GBP
€2732EUR$2,750USD£2,271GBP
- Report
- November 2023
- 30 Pages
Global
From €1912EUR$1,925USD£1,590GBP
€2732EUR$2,750USD£2,271GBP
- Report
- November 2023
- 30 Pages
Global
From €2260EUR$2,275USD£1,879GBP
€3229EUR$3,250USD£2,684GBP
- Report
- July 2023
- 128 Pages
Global
From €5216EUR$5,250USD£4,336GBP
€7451EUR$7,500USD£6,195GBP
- Report
- April 2023
- 240 Pages
Global
From €2260EUR$2,275USD£1,879GBP
€3229EUR$3,250USD£2,684GBP
- Report
- February 2023
- 30 Pages
Japan
From €1912EUR$1,925USD£1,590GBP
€2732EUR$2,750USD£2,271GBP
- Report
- February 2023
- 30 Pages
Global
From €1912EUR$1,925USD£1,590GBP
€2732EUR$2,750USD£2,271GBP
- Report
- February 2023
- 30 Pages
Global
From €1912EUR$1,925USD£1,590GBP
€2732EUR$2,750USD£2,271GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €1912EUR$1,925USD£1,590GBP
€2732EUR$2,750USD£2,271GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €2260EUR$2,275USD£1,879GBP
€3229EUR$3,250USD£2,684GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €2260EUR$2,275USD£1,879GBP
€3229EUR$3,250USD£2,684GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €1912EUR$1,925USD£1,590GBP
€2732EUR$2,750USD£2,271GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €1912EUR$1,925USD£1,590GBP
€2732EUR$2,750USD£2,271GBP
- Drug Pipelines
- December 2022
- 30 Pages
Global
From €1912EUR$1,925USD£1,590GBP
€2732EUR$2,750USD£2,271GBP
The Dermatological Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and skin cancer. Dermatological drugs are typically administered topically, although some may be taken orally.
The Dermatological Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies are engaged in research and development of new drugs, as well as marketing and distribution of existing products. Additionally, many smaller companies are involved in the production of generic dermatological drugs. Show Less Read more